Empresa Exicure Inc Other OTC
Acciones
US30205M1018
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Immuno-oncology Therapeutics
100,0
%
| 0 | 100,0 % | 29 | 100,0 % | -6.068,12 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 29 | 100,0 % | -6.068,12 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Paul Kang
CEO | Chief Executive Officer | 63 | 24/02/23 |
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 01/12/22 |
Investor Relations Contact | 47 | - | |
Joshua Miller
AUD | Comptroller/Controller/Auditor | 48 | 01/04/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 01/12/22 |
Paul Kang
CEO | Chief Executive Officer | 63 | 24/02/23 |
Hyuk Joon Ko
BRD | Director/Board Member | - | 23/08/23 |
Dongho Lee
BRD | Director/Board Member | - | 21/08/23 |
Hojoon Lee
BRD | Director/Board Member | - | 23/08/23 |
Minhee Eom
BRD | Director/Board Member | - | 26/09/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 8 648 307 | 4 753 248 ( 54,96 %) | 0 | 54,96 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,52 % | 111 mil M | |
+11,38 % | 106 mil M | |
-12,64 % | 22,24 mil M | |
+0,44 % | 21,25 mil M | |
-4,18 % | 18,97 mil M | |
-37,85 % | 18,52 mil M | |
-8,58 % | 16,81 mil M | |
+37,41 % | 12,54 mil M | |
-23,95 % | 8089,74 M |